The Trendlines Group Signs Collaboration Agreement with Roper St. Francis - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
The Trendlines Group Signs Collaboration Agreement with Roper St. Francis


The Trendlines Group Signs Collaboration Agreement with Roper St. Francis

PR Newswire

MISGAV, Israel, January 21, 2014 /PRNewswire/ --

Trendlines Labs (a unit of the Trendlines Group) recently signed an agreement for collaboration with Roper St. Francis Healthcare.

     (Logo: http://photos.prnewswire.com/prnh/20140121/666259-a )

     (Logo: http://photos.prnewswire.com/prnh/20140121/666259-b )

Together, the parties will collaborate on the development of new medical device inventions and lower-cost solutions for known clinical problems. This partnership will also include inventing products for unmet medical needs identified by physicians and medical professionals.

Jacobo Mintzer, MD, director of the RSF Clinical Biotechnology Research Institute, leads the initiative at RSF, and will continue to work closely with top leadership at Trendlines as the partnership moves forward.  

Experience, diversity and knowledge are the major components of strength in the collaboration, Dr. Mintzer said.

"As a part of our investment in medical device technology, we have decided to focus first on inventions," Dr. Mintzer said. "In order to do this, we established a multi-disciplinary group with knowledge and experience in a variety of technologies. This group will work closely with Trendlines Labs."

Yosi Hazan, CEO of Trendlines Labs, believes the collaboration with RSF confirms its model of establishing relationships and investing with smart decision makers and clinical experts in the medical industry.

"The robust clinical experience of RSF complements our technological and business knowledge and forges a powerful mechanism for medical innovation," Hazan said.

About Trendlines

The Trendlines Group ( http://www.trendlines.com ) creates and develops businesses to improve the human condition. Partnering with passionate Israeli innovators, Trendlines invents, incubates, and invests in game-changing, early-stage medical and agricultural technologies. Trendlines provides entrepreneurs with an environment that nurtures curiosity and leadership and presents investors with significant opportunities. Trendlines Labs is an in-house invention " factory, " focused on inventing medical technologies and products to meet critical unmet needs.

About Roper St. Francis Healthcare

Roper St. Francis Healthcare is the Lowcountry's only private, not-for-profit healthcare provider. The 657-bed system comprises more than 90 facilities in seven counties and provides the full range of primary and specialty care. Learn more at  rsfh.com .

Media contact:
Shane Ellis
shane.ellis@rsfh.com
w: +1-(843)-720-9456
c: +1-(843)-494-8040

SOURCE The Trendlines Group

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
88%
Borrow lightly from EMA's pathway program?
4%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here